Drug Database
Back to search

Poland· PL-100456423

Rosulip Plus

A rosuvastatin and ezetimibe product containing rosuvastatinum + ezetimibum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC C10BA06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedRosulip PlusATCC10BA06REGISTER NO.PL-100456423PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rosuvastatinum + ezetimibumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rosuvastatin and ezetimibe is registered in 9 of 19 countries.

Countries holding a registration under ATC C10BA06 (rosuvastatin and ezetimibe), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search rosuvastatin and ezetimibe products by name

Rosuvastatin and ezetimibe · ATC C10BA06

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Rosuvastatinum + Ezetimibum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
C10BA06
ATC class
Rosuvastatin and ezetimibe
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991462628
  • gtin
    05909991462635
  • gtin
    05909991462642

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Rosuvastatin and ezetimibe in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin and ezetimibe products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Arosuva Plus Ezetimib, Ezerosu
  • Belgium · Cholecomb, Ezetimibe/Rosuvastatin Sandoz
  • Bulgaria · Rosteza 10 Mg/10 Mg, Rosteza 20 Mg/10 Mg
  • Cyprus · Celmantin Plus, Lipocomb
  • Czechia · Delipid Plus, Refidoro
  • Germany · Antilia, Ezehron Duo
  • Estonia · Delipid Plus, Rosazimib
  • Spain · Alzil Plus, Arrox Plus
  • Finland · Rosuvastatin/Ezetimib Krka, Rosuvastatin/Ezetimibe Ratiopharm
  • France · Liporosa, Quiloga
  • Greece · Celmantin Plus, Co-Rosuvador
  • Croatia · Arosen, Co-Roswera
  • Hungary · Co-Xeter, Delipid Plus
  • Ireland · Lipocomb, Rosuvastatin/Ezetimibe Krka
  • Italy · Aurozeb, Cholecomb
  • Lithuania · Roselia, Sorvitimb
  • Luxembourg · Cholecomb, Myrosor
  • Latvia · Rosazimib, Rosulip
  • Malta · Ezehron Duo, Lipocomb
  • Netherlands · Ayadont, Cholecomb
  • Norway · Rosteze, Rosuvastatin/Ezetimib Krka
  • Portugal · Colroset, Lipocomb
  • Romania · Co-Roswera, Lipocomb
  • Slovenia · Refidoro, Rozor
  • Slovakia · Lipocomb, Rosazimib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1679ce37-5327-4699-adb7-28f07ea11768
GET /v1/drugs/1679ce37-5327-4699-adb7-28f07ea11768?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "10 mg + 10 mg",
  "packaging": "05909991462628 ¦ Rp ¦ 141475\n30 kaps.\n05909991462635 ¦ Rp ¦ 141476\n60 kaps.\n05909991462642 ¦ Rp ¦ 141477\n90 kaps.",
  "substance": "Rosuvastatinum 10 mg + Ezetimibum 10 mg",
  "common_name": "Rosuvastatinum + Ezetimibum",
  "pl_product_id": "100456423",
  "pozwolenie_nr": "298/21",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-08-12"
}
API referenceMCP serverPlans

See everything about rosuvastatin and ezetimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console